Dysregulated expression of SKP2 and its role in hematological malignancies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulated expression of SKP2 and its role in hematological malignancies
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 59, Issue 5, Pages 1051-1063
Publisher
Informa UK Limited
Online
2017-08-11
DOI
10.1080/10428194.2017.1359740
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells
- (2017) Jinxiang Huang et al. Cancer Research and Treatment
- Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells
- (2016) Ahmad Iskandarani et al. Journal of Translational Medicine
- Involvement of F-BOX proteins in progression and development of human malignancies
- (2016) Shahab Uddin et al. SEMINARS IN CANCER BIOLOGY
- Arsenic Trioxide Inhibits Cell Growth and Invasion via Down-Regulation of Skp2 in Pancreatic Cancer Cells
- (2015) Jian-Kun Gao et al. Asian Pacific Journal of Cancer Prevention
- Targeting the ubiquitin pathway for cancer treatment
- (2015) Jia Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The role of CD95 and CD95 ligand in cancer
- (2015) M E Peter et al. CELL DEATH AND DIFFERENTIATION
- p27 Kip1 signaling: Transcriptional and post-translational regulation
- (2015) Su Su Thae Hnit et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Primary cutaneous T-cell lymphomas: a review
- (2015) Konstantinos G Sidiropoulos et al. JOURNAL OF CLINICAL PATHOLOGY
- Therapeutic and analytical applications of arsenic binding to proteins
- (2015) Beibei Chen et al. Metallomics
- Skp2-Dependent Ubiquitination and Activation of LKB1 Is Essential for Cancer Cell Survival under Energy Stress
- (2015) Szu-Wei Lee et al. MOLECULAR CELL
- SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination
- (2015) Wenfu Lu et al. Oncotarget
- Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2
- (2015) Zhiwei Wang et al. Oncotarget
- E3-ligase Skp2 regulates β-catenin expression and maintains hematopoietic stem cell homing
- (2014) Jing Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Protein ubiquitination in lymphoid malignancies
- (2014) Yibin Yang et al. IMMUNOLOGICAL REVIEWS
- Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma
- (2014) Y Yang et al. LEUKEMIA
- Targeting BCL2 for the Treatment of Lymphoid Malignancies
- (2014) Mary Ann Anderson et al. SEMINARS IN HEMATOLOGY
- Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells
- (2014) Y-J Liao et al. Cell Death & Disease
- The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
- (2014) Tasuku Matsuoka et al. Cancers
- S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression
- (2013) S-Y Xu et al. CANCER GENE THERAPY
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
- (2013) Chia-Hsin Chan et al. CELL
- Arsenic Binding to Proteins
- (2013) Shengwen Shen et al. CHEMICAL REVIEWS
- Prodigiosin down-regulates SKP2 to induce p27KIP1 stabilization and antiproliferation in human lung adenocarcinoma cells
- (2012) Hsin-Ying Hsieh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Acetylation-Dependent Regulation of Skp2 Function
- (2012) Hiroyuki Inuzuka et al. CELL
- Akt-dependent Skp2 mRNA translation is required for exiting contact inhibition, oncogenesis, and adipogenesis
- (2012) Veronique Nogueira et al. EMBO JOURNAL
- Kaposi Sarcoma-associated Herpesvirus vIRF-3 Protein Binds to F-box of Skp2 Protein and Acts as a Regulator of c-Myc Protein Function and Stability
- (2012) Petra Baresova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of vitamin D receptor (VDR) in lung adenocarcinoma
- (2012) So Hee Kim et al. LUNG CANCER
- PI3K regulation of the SKP-2/p27 axis through mTORC2
- (2012) K Shanmugasundaram et al. ONCOGENE
- Skp2 is a Promising Therapeutic Target in Breast Cancer
- (2012) Zhiwei Wang et al. Frontiers in Oncology
- The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs
- (2011) S. Rodriguez et al. BLOOD
- The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal
- (2011) J. Wang et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- 1,2,3,4,6-Penta-O-galloyl-β-d-glucose, Quercetin, Curcumin and Lycopene Induce Cell-Cycle Arrest in MDA-MB-231 and BT474 Cells through Downregulation of Skp2 Protein
- (2011) Hsiu-Chen Huang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Gallic Acid Induces G2/M Phase Arrest of Breast Cancer Cell MCF-7 through Stabilization of p27Kip1Attributed to Disruption of p27Kip1/Skp2 Complex
- (2011) Jeng-Dong Hsu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Development of natural anti-tumor drugs by microorganisms
- (2011) Chia-Che Chang et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Loss of nuclear pro–IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma
- (2011) Clara Curiel-Lewandrowski et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of Skp2 Expression and Activity and Its Role in Cancer Progression
- (2011) Chia-Hsin Chan et al. TheScientificWorldJOURNAL
- The Prognostic Value of Skp2 Expression in Egyptian Diffuse Large B-Cell Lymphoma
- (2011) Asmaa Gaber Abdou et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis
- (2011) Guocan Wang et al. Chinese Journal of Cancer
- Apigenin induces apoptosisviadownregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells
- (2010) A. R. Hussain et al. CELL PROLIFERATION
- New Insights on the Antitumoral Properties of Prodiginines
- (2010) R. Perez-Tomas et al. CURRENT MEDICINAL CHEMISTRY
- Ubiquitin networks in cancer
- (2010) Vladimir Kirkin et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL)
- (2010) Olivera Markovic et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells
- (2010) Jing-Yi Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Skp2 Directs Myc-Mediated Suppression of p27Kip1 yet Has Modest Effects on Myc-Driven Lymphomagenesis
- (2010) J. B. Old et al. MOLECULAR CANCER RESEARCH
- Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence
- (2010) Hui-Kuan Lin et al. NATURE
- Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab
- (2009) R. Seki et al. ANNALS OF ONCOLOGY
- p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation
- (2009) A. Furuhata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lack of T-Cell Receptor-Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death
- (2009) C.-D. Klemke et al. CANCER RESEARCH
- Ubiquitin-mediated control of oncogene and tumor suppressor gene products
- (2009) Kyoko Kitagawa et al. CANCER SCIENCE
- Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway
- (2009) Anchalee Techasen et al. CANCER SCIENCE
- The ubiquitin pathway: An emerging drug target in cancer therapy
- (2009) Sudharsana Rao Ande et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer
- (2009) Shahab Uddin et al. LABORATORY INVESTIGATION
- Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells
- (2009) Azhar R. Hussain et al. LEUKEMIA & LYMPHOMA
- Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells
- (2009) Jing-Yi Chen et al. LEUKEMIA RESEARCH
- F-Box-Directed CRL Complex Assembly and Regulation by the CSN and CAND1
- (2009) Michael W. Schmidt et al. MOLECULAR CELL
- Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction
- (2009) Daming Gao et al. NATURE CELL BIOLOGY
- Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB
- (2009) Hui-Kuan Lin et al. NATURE CELL BIOLOGY
- Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer
- (2008) Dan D. Hershko CANCER
- Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer
- (2008) S. Uddin et al. CANCER RESEARCH
- EGCG Stabilizes p27kip1in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein
- (2008) Hsiu-Chen Huang et al. ENDOCRINOLOGY
- Pharmacotherapy of large B-cell lymphoma
- (2008) Maricer P Escalón et al. EXPERT OPINION ON PHARMACOTHERAPY
- S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma
- (2008) S Uddin et al. JOURNAL OF PATHOLOGY
- Skp2/p27 expression profile is correlated with Epstein–Barr virus status in extranodal nasal-type natural killer cell lymphoma
- (2008) Mo Xiang-Lan et al. Translational Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More